Literature DB >> 2683864

Immunodetection of DNA with biotinylated RNA probes: a study of reactivity of a monoclonal antibody to DNA-RNA hybrids.

F Coutlée1, L Bobo, K Mayur, R H Yolken, R P Viscidi.   

Abstract

A quantitative, nonisotopic hybridization assay which measures specific DNA-RNA hybrids is described. A biotinylated RNA probe is reacted in solution with a DNA target and the labeled hybrids are immobilized onto a solid phase surface with an antibiotin antibody. Bound hybrids are detected with a beta-galactosidase-labeled monoclonal antibody against DNA-RNA hybrids and are quantitated with the addition of a fluorogenic substrate. In a model system using pSP65 or pGEM4 plasmids and transcripts, biotinylated RNA probes allowed detection of 5 pg of DNA in 10(6) pg of exogenous nucleic acids in 1000 min. Signals generated in the system depended on input target length. A nucleic acid target of 25 bases was still detectable in the assay. Human immunodeficiency virus type 1 (HIV-1) DNA was amplified in the polymerase chain reaction with Taq polymerase and a set of primers for the pol gene, one of which contained T7 RNA polymerase promoter sequences. A HIV-RNA probe of 326 bases was transcribed with T7 RNA polymerase using polymerase chain reaction (PCR) amplified DNA as a template. The RNA probe of 326 bases performed as well as a RNA probe of 2588 bases for detection of a DNA segment of 355 bp. For detection of dilutions of HIV-1 with PCR, a set of primers (outer set) was used for amplification of HIV-1 DNA. In a separate reaction a set of primers nested between the first set generated through PCR an amplified DNA fragment with the T7 promoter. This fragment was transcribed for the synthesis of a biotinylated RNA probe. This probe could then be reacted with material amplified with the outer set of primers. Ten copies of HIV-DNA could be detected with this procedure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2683864     DOI: 10.1016/0003-2697(89)90399-0

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  12 in total

1.  Confirmatory polymerase chain reaction testing for Chlamydia trachomatis in first-void urine from asymptomatic and symptomatic men.

Authors:  J B Mahony; K E Luinstra; J W Sellors; D Jang; M A Chernesky
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

2.  Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications.

Authors:  Q Chou; M Russell; D E Birch; J Raymond; W Bloch
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

3.  Detection of transcripts of human papillomaviruses 16 and 18 in cancer-derived cell lines and cervical biopsies by enzyme immunoassay for DNA-RNA hybrids following solution hybridization.

Authors:  F Coutlée; K V Shah; J S Rader; J L Currie; R P Viscidi
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

4.  Production and characterization of anti-DNA-RNA monoclonal antibodies and their application in Listeria detection.

Authors:  I Fliss; M St Laurent; E Emond; R Lemieux; R E Simard; A Ettriki; S Pandian
Journal:  Appl Environ Microbiol       Date:  1993-08       Impact factor: 4.792

5.  Comparing Rapid and Specific Detection of Brucella in Clinical Samples by PCR-ELISA and Multiplex-PCR Method.

Authors:  Sharareh Mohammad Hasani; Reza Mirnejad; Jafar Amani; Mohamad Javad Vafadar
Journal:  Iran J Pathol       Date:  2016

6.  Diagnosis of Chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay.

Authors:  L Bobo; F Coutlee; R H Yolken; T Quinn; R P Viscidi
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

7.  Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma.

Authors:  L Bobo; N Novak; H Mkocha; S Vitale; S West; T C Quinn
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

8.  Detection of human papillomavirus DNA in cervical lavage specimens by a nonisotopic consensus PCR assay.

Authors:  F Coutlée; D Provencher; H Voyer
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

9.  Evaluation of infection with human immunodeficiency virus type 1 by using nonisotopic solution hybridization for detection of polymerase chain reaction-amplified proviral DNA.

Authors:  F Coutlée; P Saint-Antoine; C Olivier; H Voyer; A Kessous-Elbaz; F Berrada; P Bégin; L Giroux; R Viscidi
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

10.  Detection of polymerase chain reaction-amplified human immunodeficiency virus type 1 proviral DNA with a digoxigenin-labeled RNA probe and an enzyme-linked immunoassay.

Authors:  Y He; F Coutlée; P Saint-Antoine; C Olivier; H Voyer; A Kessous-Elbaz
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.